Gibbs Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$923K Buy
3,125
+1,482
+90% +$440K 0.12% 169
2025
Q4
$431K Buy
1,643
+213
+15% +$57.9K 0.1% 220
2025
Q3
$386K Buy
1,430
+87
+6% +$23.7K 0.09% 237
2025
Q2
$370K Buy
1,343
+78
+6% +$21.2K 0.07% 263
2025
Q1
$336K Buy
1,265
+169
+15% +$41.7K 0.08% 234
2024
Q4
$255K Buy
1,096
+71
+7% +$16.3K 0.07% 252
2024
Q3
$226K Buy
+1,025
New +$212K 0.07% 244

Other funds holding CME

Gibbs Wealth Management's CME Position: Q1 2026 in Review

Gibbs Wealth Management increased its CME Group (CME) stake by 90% in Q1 2026, buying an estimated $440K and bringing the position to 3,125 shares worth $923K. The position accounts for 0.12% of the portfolio, ranked #169.

Gibbs Wealth Management first reported a position in CME in Q3 2024 and has held it in 7 quarters since. 1,803 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Gibbs Wealth Management held 3,125 shares of CME Group worth $923K as of Q1 2026.
  • Gibbs Wealth Management bought 1,482 CME Group shares in Q1 2026, an estimated $440K.
  • CME Group made up 0.12% of Gibbs Wealth Management's portfolio in Q1 2026, its #169 holding.
  • Gibbs Wealth Management first reported a position in CME Group in Q3 2024 and has held it in 7 quarters since.
  • 1,803 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.